Found 14 matching trials
Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic Melanoma
PHASE2The purpose of this study is to find out how effective an investigational d...
Location
H. Lee Moffitt Cancer Center & Research Institute
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
PHASE2The purpose of this study is to evaluate whether treatment with a new drug ...
Location
Multiple Locations
ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-independent Prostate Cancer
PHASE2The purpose of this study is to evaluate whether treatment with a new drug ...
Location
Multiple Locations
Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-small-cell Lung Cancer
PHASE2Phase 2 study to investigate the efficacy and tolerability of epothilone ZK...
Location
Multiple Locations
Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma
PHASE2RATIONALE: Drugs used in chemotherapy, such as epothilone ZK-219477, work i...
Location
Centre Hospitalier Universitaire Vaudois
A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung Cancer
PHASE1The purpose of the study is to determine whether the study drug ZK 219477 (...
Location
Multiple Locations
Efficacy and Safety Study of ZK219477 in Patients With Recurrent Ovarian Cancer
PHASE2The purpose of this study is to determine if this epothilone leads to a res...
Location
Multiple Locations
ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases
PHASE2The purpose of this research study is to determine the effects (good and ba...
Location
Dana-Farber Cancer Institute
Safety and Efficacy Study of a New Chemotherapy Agent to Treat Small Cell Lung Cancer
PHASE2The purpose of this study is to determine whether the study drug is effecti...
Location
Multiple Locations
Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)
PHASE2This study investigates the safety and efficacy of Acetyl-L-Carnitine and c...
Location
Multiple Locations